SavedAdd your journal

Journals / Erciyes Medical Journal / 2022 / Cilt: 44 - Sayı: 3

Pituitary Insufficiency Diagnosed After Coronavirus Disease-19: A Case Report

Mina Gülfem KAYA
Cem ERTÜRK
Muhammet GÜVEN
Pages
347–349
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Physicians should be aware about the systemic effects of SARS-CoV-2 infection and follow-up patients with a history of COVID-19 accordingly.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background: Severe acute respiratory syndrome-coronavirus (SARS-CoV) and SARS-CoV-2 might affect the hypothalamic- pituitary-adrenal axis.
📊
Key Findings & Data:This paper presents a rare case of pituitary insufficiency diagnosed after CoV disease (COVID)-19.
💡
Conclusion & Impact:Physicians should be aware about the systemic effects of SARS-CoV-2 infection and follow-up patients with a history of COVID-19 accordingly.
🔬Design:Experimental Field Trial
📍Scope:2020 Verileri
⚙️Variables:Domain Parameters

Abstract

Background: Severe acute respiratory syndrome-coronavirus (SARS-CoV) and SARS-CoV-2 might affect the hypothalamic- pituitary-adrenal axis. This paper presents a rare case of pituitary insufficiency diagnosed after CoV disease (COVID)-19. Case Report: On December 7, 2020, a 67-year-old male patient presented to the Endocrinology Department of Lokman Hekim University with weakness, weight loss, and abdominal pain lasting for 3 weeks. In his medical history, he had a positive real-time polymerase chain reaction test result for SARS-CoV-2 based on the nasopharyngeal swab analyzed on September 30. Central hypothyroidism, secondary adrenal insufficiency, hypogonadotropic hypogonadism, and a low dehydroepiandrosterone- sulfate level were detected in the laboratory examinations. Steroid therapy was initiated. Conclusion: Non-specific adrenal insufficiency symptoms such as fatigue and weakness, and psychosomatic symptoms can be seen during the course of COVID-19 or the post-COVID-19 period. Physicians should be aware about the systemic effects of SARS-CoV-2 infection and follow-up patients with a history of COVID-19 accordingly.

🔖

Cite This Article

KAYA, M. G., ERTÜRK, C., GÜVEN, M. (2022). Pituitary Insufficiency Diagnosed After Coronavirus Disease-19: A Case Report. Erciyes Medical Journal, Cilt: 44 - Sayı: 3, 347–349. https://ajindex.com/articles/502125

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (7)

  1. Li X, Geng M, Peng Y, Meng L, Lu S. Molecular immune pathogenesis and diagnosis of COVID-19. J Pharm Anal 2020; 10(2): 102–8
  2. Leow MK, Kwek DS, Ng AW, Ong KC, Kaw GJ, Lee LS. Hypocortisolism in survivors of severe acute respiratory syndrome (SARS). Clin Endocrinol (Oxf) 2005; 63(2): 197–202
  3. Wei L, Sun S, Zhang J, Zhu H, Xu Y, Ma Q, et al. Endocrine cells of the adenohypophysis in severe acute respiratory syndrome (SARS). Biochem Cell Biol 2010; 88(4): 723–30
  4. Pal R, Banerjee M. COVID-19 and the endocrine system: Exploring the unexplored. J Endocrinol Invest 2020; 43(7): 1027–31
  5. Chang L, Yan Y, Wang L. Coronavirus disease 2019: Coronaviruses and blood safety. Transfus Med Rev 2020; 34(2): 75–80
  6. Ding Y, He L, Zhang Q, Huang Z, Che X, Hou J, et al. Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: Implications for pathogenesis and virus transmission pathways. J Pathol 2004; 203(2): 622–30
  7. Alzahrani AS, Mukhtar N, Aljomaiah A, Aljamei H, Bakhsh A, Alsudani N, et al. The impact of COVID-19 viral infection on the hypothalamic- pituitary-adrenal axis. Endocr Pract 2021; 27(2): 83–9.